Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|September 11, 2016
Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivoTsui-Hwa Tseng, Wea-Lung Lin, Zi-Hui Chen, et al.
Acta Cytologica|June 4, 2002
Cytologic changes in small hepatocellular carcinomas after radiofrequency ablationShi-Ming Lin, Chien-Heng Shen, Deng-Yn Lin, et al.
International Journal of Molecular Sciences|May 14, 2022
Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with AilanthoidolTsui-Hwa Tseng, Chau-Jong Wang, Yean-Jang Lee, et al.
Chang Gung Medical Journal|November 1, 2011
Serum HCV RNA level is not associated with insulin resistance and metabolic syndrome in chronic hepatitis C patients with genotype 1 or 2 infectionHao-Chun Huang, Chia-Sheng Chuang, Yung-Yu Hsieh, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 6, 2019
Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical dataChern-Horng Lee, Chee-Jen Chang, Yu-Jr Lin, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2016
Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopeniaCih-En Huang, Yi-Yang Chen, Jung-Jung Chang, et al.
Scientific Reports|September 29, 2024
Survival benefit of sequential curative treatment for TACE suitable BCLC stage B HCC patientsYuan-Jie Ding, Te-Sheng Chang, Chien-Heng Shen, et al.
Hepatology International|January 4, 2022
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trialWei-Ting Chen, Shi-Ming Lin, Wei-Chen Lee, et al.
Chang Gung Medical Journal|December 29, 2009
FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitisYung-Yu Hsieh, Shui-Yi Tung, I-Lin Lee, et al.
Pageof 5